Masimo Corp
MASIDelisted Jun 10, 2026- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000937556
Masimo Corp was delisted on Jun 10, 2026; its insiders filed their last Form 4 on Jun 12, 2026; 453 institutions reported holding it in 13F filings for Q1 2026, worth $9.69B in total; Soros Fund Management was the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:02 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $151.5M (9.9% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 16, 2025 | Jan 10, 2024 | Feb 28, 2023 | Jan 11, 2022 |
| Revenue | $1.53B | $2.09B | $2.05B | $2.04B | $1.24B |
| Cost of revenue | $581.7M | $1.09B | $1.04B | $977.0M | $430.8M |
| Gross profit | $945.2M | $1.00B | $1.00B | $1.06B | $808.3M |
| Operating expenses | $635.2M | $1.27B | $867.0M | $848.8M | $532.5M |
| Research and development | $126.4M | $222.8M | $175.2M | $191.4M | $137.2M |
| Selling, general and administrative | $506.0M | $743.8M | $664.0M | $657.4M | $395.3M |
| Operating income | $310.0M | -$266.7M | $136.5M | $210.0M | $275.8M |
| Interest expense | – | – | $50.3M | $25.7M | $355.0K |
| Income tax | $64.9M | -$400.0K | $6.60M | $49.9M | $44.7M |
| Net income | -$151.5M | -$304.9M | $81.5M | $143.5M | $229.6M |
| EPS, basic | $-2.83 | $-5.72 | $1.54 | $2.68 | $4.16 |
| EPS, diluted | $-2.80 | $-5.72 | $1.51 | $2.60 | $3.98 |
| Weighted shares, basic | 53.6M | 53.3M | 52.8M | 53.6M | 55.2M |
| Weighted shares, diluted | 54.2M | 53.3M | 54.1M | 55.2M | 57.7M |
| Margins and growth | |||||
| Gross margin | 61.9% | 48.0% | 49.0% | 52.0% | 65.2% |
| Operating margin | 20.3% | -12.7% | 6.7% | 10.3% | 22.3% |
| Net margin | -9.9% | -14.6% | 4.0% | 7.0% | 18.5% |
| Revenue growth, year over year | −27.1% | +2.3% | +0.6% | +64.3% | +8.3% |
| Net income growth, year over year | – | −474.1% | −43.2% | −37.5% | −4.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 16, 2025 | Jan 10, 2024 | Feb 28, 2023 | Jan 11, 2022 |
| Cash and equivalents | $152.3M | $177.6M | $163.0M | $202.9M | $745.3M |
| Accounts receivable | $275.8M | – | $355.5M | – | – |
| Inventory | $380.3M | $459.2M | $545.0M | $501.0M | $201.4M |
| Total current assets | $926.0M | $1.23B | $1.23B | $1.31B | $1.24B |
| Property, plant and equipment | $355.1M | $381.6M | $424.4M | $402.5M | $272.8M |
| Goodwill | $101.0M | $96.7M | $407.7M | $445.4M | $100.3M |
| Intangible assets | $52.1M | $558.2M | $652.3M | $722.6M | $72.5M |
| Total assets | $1.70B | $2.63B | $3.04B | $3.21B | $1.89B |
| Accounts payable | $103.0M | $252.8M | $251.5M | $276.8M | $75.6M |
| Short-term debt | $6.30M | $37.3M | $34.3M | $15.1M | – |
| Total current liabilities | $371.6M | $617.7M | $563.8M | $630.0M | $267.7M |
| Long-term debt | $518.0M | $727.9M | $871.7M | $941.6M | – |
| Total liabilities | $977.7M | $1.57B | $1.68B | $1.87B | $336.8M |
| Shareholders' equity | $721.2M | $1.05B | $1.36B | $1.34B | $1.55B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Jan 3, 2026 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Jan 1, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 16, 2025 | Jan 10, 2024 | Feb 28, 2023 | Jan 11, 2022 |
| Operating cash flow | $217.8M | $196.4M | $94.1M | $29.4M | $264.8M |
| Capital expenditures | $19.4M | $20.0M | $44.0M | $52.8M | $25.5M |
| Free cash flow | $198.4M | $176.4M | $50.1M | -$23.4M | $239.3M |
| Depreciation and amortization | $38.8M | $103.0M | $98.3M | $136.1M | $35.6M |
| Stock-based compensation | $35.8M | $41.5M | $7.00M | $47.7M | $44.6M |
| Share buybacks | $363.7M | $0 | $0 | $401.5M | $128.9M |
| Investing cash flow | $275.1M | -$51.2M | -$81.2M | -$1.06B | -$37.5M |
| Financing cash flow | -$520.7M | -$125.6M | -$57.1M | $520.4M | -$122.4M |
| Net change in cash | -$28.1M | $13.2M | -$41.4M | -$538.8M | $103.4M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 2.3% | 2.0% | 0.3% | 2.3% | 3.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.